Brief: Neubase Therapeutics Reports Q1 Loss Per Share Of $0.26
26/03/2020 21:33
March 26 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE
FIRST
FISCAL QUARTER OF 2020
* Q1 LOSS PER SHARE $0.26
* Q1 EARNINGS PER SHARE ESTIMATE $-0.32 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX2DwCKz
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet